Concentrating attention on a visual task can render you momentarily ‘deaf’ to sounds at normal levels, reports a new UCL study funded by the Wellcome Trust.
Portable device can quickly determine the extent of an eye injury
An engineer and an ophthalmologist are developing a portable sensor that can quickly and inexpensively determine whether an eye injury is mild or severe.
Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems
Roche today announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc., a privately-held company headquartered in Wilmington, Massachusetts, US.
Reticare_USA to Exhibit at 2016 International CES, booth #36511, LVCC-SOUTH HALL 4
TAMPA, Fla.–(BUSINESS WIRE)–Reticare the world leader in eye protection from high energy light will show case two new innovative products at CES 2016 — Reticare Glasses and Reticare Glass.
Mycotic Ulcer Treatment Trial II
Status: Active, not recruiting,
Condition Summary: Corneal Ulcer; Eye Infections, Fungal
Issues with safety of anti-VEGF agents in infants with ROP call for further investigation
VIENNA — Increasing evidence supports the efficacy of anti-VEGF agents in the treatment of retinopathies, but safety concerns remain with their use in infants, requiring further investigation, according to a specialist speaking at the Advanced Retinal Therapy meeting. Focusing on retinopathy of prematurity, Mary Elizabeth Hartnett, MD, said that multiple case series and small trials as well as the BEAT-ROP study found efficacy in reducing intravitreal neovascularization and facilitating physiologic retinal vascular development in some cases.